Cargando…

Reduced severity of SARS-CoV-2 infection by Kappa variant of interest (B.1.617.1) in a healthcare worker post-vaccination from Gujarat, India

Detalles Bibliográficos
Autores principales:	Sahay, Rima Rakeshkumar, Shete, Anita M., Sapkal, Gajanan N., Deshpande, Gururaj R., Shah, Arti D., Kumar, Sanjay, Abraham, Priya, Yadav, Pragya D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807192/ https://www.ncbi.nlm.nih.gov/pubmed/35975349 http://dx.doi.org/10.4103/ijmr.ijmr_1390_21

Ejemplares similares

Genome Sequences of the Delta Variant (B.1.617.2) and the Kappa Variant (B.1.617.1) Detected in Morocco
por: Melloul, Marouane, et al.
Publicado: (2021)

Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
por: Shete, Anita M., et al.
Publicado: (2022)

SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera
por: Sahay, Rima R., et al.
Publicado: (2022)

Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion
por: Ren, Wenlin, et al.
Publicado: (2022)

Broadly Reactive SARS-CoV-2-Specific T-Cell Response and Participation of Memory B and T Cells in Patients with Omicron COVID-19 Infection
por: Yadav, Pragya D., et al.
Publicado: (2023)

A case with SARS-CoV-2 reinfection from India
por: Munivenkatappa, Ashok, et al.
Publicado: (2022)

Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern
por: Yadav, Pragya D., et al.
Publicado: (2022)

Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
por: Yadav, Pragya D., et al.
Publicado: (2022)

Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model
por: Yadav, Pragya, et al.
Publicado: (2022)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

The neutralization of B.1.617.1 and B.1.1.529 sera from convalescent patients and BBIBP-CorV vaccines
por: Yang, Xinyi, et al.
Publicado: (2022)

Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection
por: Epaulard, Olivier, et al.
Publicado: (2022)

A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein
por: Srivastava, Vijay Kumar, et al.
Publicado: (2021)

Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants
por: Patil, Dilip R., et al.
Publicado: (2023)

Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of the MSD platform
por: Patil, Rajashree, et al.
Publicado: (2023)

Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern
por: Mohandas, Sreelekshmy, et al.
Publicado: (2022)

Canine Distemper Virus in Asiatic Lions of Gujarat State, India
por: Mourya, Devendra T., et al.
Publicado: (2019)

Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months
por: Sahay, Rima R., et al.
Publicado: (2022)

Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model
por: Yadav, Pragya D., et al.
Publicado: (2022)

Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis
por: Mourya, Devendra T., et al.
Publicado: (2020)

Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters
por: Mohandas, Sreelekshmy, et al.
Publicado: (2022)

Identification and phylogenetic analysis of herpes simplex virus-1 from clinical isolates in India
por: Nyayanit, Dimpal A., et al.
Publicado: (2019)

SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
por: Mohandas, Sreelekshmy, et al.
Publicado: (2021)

Difference in vector ticks dropping rhythm governs the epidemiology of Crimean-Congo haemorrhagic fever & Kyasanur forest disease in India
por: Mourya, Devendra T., et al.
Publicado: (2016)

Acute Encephalitis with Atypical Presentation of Rubella in Family Cluster, India
por: Bharadwaj, Sumit D., et al.
Publicado: (2018)

SARS-CoV-2 & influenza A virus co-infection in an elderly patient with pneumonia
por: Munivenkatappa, Ashok, et al.
Publicado: (2021)

Ghosts of the past: Elemental composition, biosynthesis reactions and thermodynamic properties of Zeta P.2, Eta B.1.525, Theta P.3, Kappa B.1.617.1, Iota B.1.526, Lambda C.37 and Mu B.1.621 variants of SARS-CoV-2
por: Popovic, Marko, et al.
Publicado: (2023)

Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines
por: Yang, Yong, et al.
Publicado: (2021)

Zika virus: Indian perspectives
por: Mourya, Devendra T., et al.
Publicado: (2016)

Sequential determination of viral load, humoral responses and phylogenetic analysis in fatal and non-fatal cases of Crimean-Congo hemorrhagic fever patients from Gujarat, India, 2019
por: Sahay, Rima R., et al.
Publicado: (2021)

Discovery of Hybrid Thiouracil–Coumarin Conjugates as Potential Novel Anti-SARS-CoV-2 Agents Targeting the Virus’s Polymerase “RdRp” as a Confirmed Interacting Biomolecule
por: Vishwanath, Divakar, et al.
Publicado: (2023)

Impact of E484Q and L452R Mutations on Structure and Binding Behavior of SARS-CoV-2 B.1.617.1 Using Deep Learning AlphaFold2, Molecular Docking and Dynamics Simulation
por: Jiao, Yanqi, et al.
Publicado: (2023)

Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
por: Deshpande, Gururaj Rao, et al.
Publicado: (2020)

Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection
por: Mohandas, Sreelekshmy, et al.
Publicado: (2020)

Understanding the dynamics of IgM & IgG antibodies in COVID-19-positive patients
por: Kaduskar, Ojas, et al.
Publicado: (2022)

Prevalence and Pattern of Skin Diseases in Tribal Villages of Gujarat: A Teledermatology Approach
por: Singhal, Rochit Rajesh, et al.
Publicado: (2020)

Crimean Congo hemorrhagic fever serosurvey in humans for identifying high-risk populations and high-risk areas in the endemic state of Gujarat, India
por: Mourya, Devendra T., et al.
Publicado: (2019)

Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells
por: Nyayanit, Dimpal A., et al.
Publicado: (2020)

Molecular characterization of varicella zoster virus isolated from clinical samples in India
por: Nyayanit, Dimpal Amol, et al.
Publicado: (2021)

Community transmission of SARS-CoV-2 with B.1.1.7 lineage in Mumbai, India
por: Shastri, Jayanthi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_18ebjtsiehf41qj94m4n68pddp